Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study

OBJECTIVE: To assess the long-term safety, tolerability, and efficacy of fremanezumab, a fully humanized monoclonal antibody approved for the preventive treatment of migraine. METHODS: A 52-week, multicenter, randomized, double-blind, parallel-group study evaluated fremanezumab monthly or quarterly...

Descripción completa

Detalles Bibliográficos
Autores principales: Goadsby, Peter J., Silberstein, Stephen D., Yeung, Paul P., Cohen, Joshua M., Ning, Xiaoping, Yang, Ronghua, Dodick, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682830/
https://www.ncbi.nlm.nih.gov/pubmed/32913018
http://dx.doi.org/10.1212/WNL.0000000000010600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682830/
https://www.ncbi.nlm.nih.gov/pubmed/32913018
http://dx.doi.org/10.1212/WNL.0000000000010600

Ejemplares similares